title: Is there a relationship between hepatitis C virus infection and antiretroviral-associated lipoatrophy?
authors.forename: H
authors.initials: H
authors.lastname: Zylberberg
authors.forename: B
authors.initials: B
authors.lastname: Nalpas
authors.forename: S
authors.initials: S
authors.lastname: Pol
authors.forename: C
authors.initials: C
authors.lastname: Bréchot
authors.forename: J P
authors.initials: JP
authors.lastname: Viard
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects*; D015658:HIV Infections / Q000150:complications* / Q000821:virology; D015497:HIV-1; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced / Q000150:complications / Q000175:diagnosis; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors